Arete Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Sell |
505
-63
| -11% | -$33.8K | 0.02% | 595 |
|
|
2025
Q1 | $239K | Buy |
568
+10
| +2% | +$4.21K | 0.02% | 614 |
|
|
2024
Q4 | $231K | Buy |
558
+17
| +3% | +$7.04K | 0.02% | 651 |
|
|
2024
Q3 | $272K | Sell |
541
-8,030
| -94% | -$4.04M | 0.02% | 549 |
|
|
2024
Q2 | $4.18M | Buy |
+8,571
| New | +$4.18M | 0.34% | 62 |
|
|
2024
Q1 | – | Sell |
-8,478
| Closed | -$4.71M | – | 522 |
|
|
2023
Q4 | $4.71M | Buy |
8,478
+2
| +0% | +$1.11K | 0.36% | 62 |
|
|
2023
Q3 | $3.71M | Buy |
8,476
+47
| +0.6% | +$20.6K | 0.64% | 28 |
|
|
2023
Q2 | $4.23M | Buy |
8,429
+6,582
| +356% | +$3.31M | 0.37% | 59 |
|
|
2023
Q1 | $924K | Buy |
1,847
+73
| +4% | +$36.5K | 0.08% | 230 |
|
|
2022
Q4 | $724M | Sell |
1,774
-46
| -3% | -$18.8M | 0.06% | 261 |
|
|
2022
Q3 | $593K | Buy |
+1,820
| New | +$593K | 0.06% | 269 |
|
|
2022
Q2 | – | Sell |
-1,444
| Closed | -$790K | – | 504 |
|
|
2022
Q1 | $790K | Sell |
1,444
-77
| -5% | -$42.1K | 0.07% | 209 |
|
|
2021
Q4 | $1M | Buy |
+1,521
| New | +$1M | 0.09% | 189 |
|
|
2021
Q3 | – | Sell |
-412
| Closed | -$206K | – | 431 |
|
|
2021
Q2 | $206K | Sell |
412
-1
| -0.2% | -$500 | 0.03% | 332 |
|
|
2021
Q1 | $202K | Sell |
413
-20
| -5% | -$9.78K | 0.03% | 398 |
|
|
2020
Q4 | $216K | Buy |
+433
| New | +$216K | 0.03% | 368 |
|
|
2018
Q4 | – | Sell |
-992
| Closed | -$248K | – | 387 |
|
|
2018
Q3 | $248K | Buy |
+992
| New | +$248K | 0.06% | 304 |
|